Abstract The B cell arm of adaptive immunity undergoes significant modifications with age. Elderly people are characterized by impaired B cell responses reflected in a reduced ability to effectively respond against viruses and bacteria. Alterations of immunity with advancing age (immunosenescence) have been widely studied in centenarians who are considered a good example of successful aging. In recent years, attention has shifted to centenarian offspring (CO) as a model of people genetically advantaged for healthy aging and longevity. Here, we describe the preliminary characterization of a proposed new population of memory B cells, defined as CD19
Introduction
B cells are key mediators of immunity. The humoral immune response includes production of antibodies against pathogens and cytokines interacting with other components of the immune system. Early stages of B cell development occur in the bone marrow from hematopoietic stem cells. The early progenitors of B lymphocytes develop into pro-, pre-, and immature B cells (LeBien and Tedder 2008 ) that, after they are controlled for autoreactivity (Carsetti et al. 1995; Palanichamy et al. 2009 ), leave the bone marrow and enter the blood as transitional B cells (Allman et al. 1993; Chung et al. 2003; Mauri and Ehrestein 2008) . In humans, peripheral blood naïve and memory B cells have been described on the basis of the differential expression of IgD and CD27 (Anolik et al. 2004; Shi et al. 2005; Wei et al. 2007; Frasca et al. 2008) (Fecteau et al. 2006; Colonna-Romano et al. 2009 ).
More recently, a different flow cytometric approach has been used to distinguish naïve from memory B cells (Allman et al. 2001 (Allman et al. , 2004 Carsetti et al. 2004; Palanichamy et al. 2009; Blair et al. 2010) . The use of two developmentally regulated markers, CD24 and CD38, in association with the B-lineage marker CD19, allowed the identification of three different B cell populations: CD19 + CD38 high CD24 high , the previously mentioned transitional B cells that also include immature B cells; CD19 
CD24
high so-called "primarily memory B cells." In a recent paper (Chaplin et al. 2011) , differentiation from transitional to mature B cells was induced by stimulation with CD180 (RP105), a toll-like receptor (TLR)-4 homologue expressed by monocytes, macrophages, dendritic cells, and B lymphocytes which regulates TLR-4 signaling and induces B cell proliferation.
Many papers have focused on modifications of the immune system in the elderly (immunosenescence) likely to contribute to their increased morbidity and mortality. It has been widely reported that elderly people show changes in B cell number, low levels of antibody production, and poor responses to recall antigens, and a collapse in B cell receptor repertoire diversity correlated with poor health status and the impairment of antibody response (Miller and Cancro 2007; Kumar and Burns 2008; Cancro et al. 2009; Gibson et al. 2009; DunnWalters and Ademokun 2010; Frasca et al. 2010; Frasca and Blomberg 2011; McElhaney et al. 2012) . Lower numbers and percentages of B cells also form part of the cluster of immune parameters collectively known as the "Immune Risk Profile" associated with 2-, 4-, and 6-year mortality of the very elderly in the Swedish OCTO/ NONA longitudinal studies (Pawelec et al. 2005) . We and others have previously demonstrated that in elderly people, IgD + CD27
− naïve B cells are significantly reduced (Gupta et al. 2005; Colonna-Romano et al. 2008 ).
In contrast, Chong et al. (2005) demonstrated that the percentage of circulating naïve B cells, identified as CD27 − , were significantly higher in the aged subjects than young subjects. This topic is still a somewhat controversial finding, as previously reviewed by us . Moreover, double-negative (DN) B cells (IgD − CD27 − ) are significantly increased in the elderly (Colonna-Romano et al. 2009; Bulati et al. 2011) , as well as under certain pathological conditions, such as systemic lupus erythematosus (SLE) (Anolik et al. 2004; Wei et al. 2007) , chronic HIV infection (Cagigi et al. 2009 ), and in healthy subjects challenged with respiratory syncytial virus (Sanz et al. 2008) .
We have recently focused on some characteristics of the naïve/memory B cell compartment of centenarian offspring (CO). This is a special population of elderly people that, like their centenarian parent(s), could have genetic and functional advantages that predispose them to healthy aging and longer survival (Terry et al. 2003 (Terry et al. , 2004 . We have shown that CO fail to show the ageassociated increase of DN (IgD − CD27 − ) B cells seen in the general elderly population. Consistent with this, the level of serum IgM in CO is within the range of the levels observed in young subjects ).
As outlined above, several distinct memory B cell populations have been identified in humans, but associations between their specific phenotype and their functions remain to be clarified. Here, we report the characterization of a proposed new population of memory B cells identified as CD19
Moreover, we show that these cells are expanded in the general elderly but not in CO who show similar levels to those observed in young donors, suggesting a more "youthful" B cell constellation. A more detailed examination of CO B cells was then performed to evaluate the expression of CD27, IgM, and IgD. It is known that IgM memory B cells are reduced in the elderly, thus predisposing them to pneumococcal infection (Shi et al. 2005; Buffa et al. 2011) . Here again, we show that CO have a "younger" B cell profile. Indeed, the percentage of these cells are not as reduced in CO as in their age-matched controls and is more similar to the percentage observed in young people. Moreover, we have examined the expression of CD180 on total B cells and found that elderly people have a significant increase of the CD19
cell subset. Finally, we have evaluated the expression of CD180 on B cell populations, identified by the differential expression of IgD/CD27 and CD38/CD24, in order to determine the age-related modulation of this marker on these cells.
Material and methods

Subjects
A total of 35 healthy Sicilians were included in the study. Twelve subjects aged 70.1±8.3 years, who were the offspring of at least one centenarian parent, were compared with seven age-matched controls without a centenarian parent (aged 69.1±9 years), eight young (28.5±1.9 years), and eight old (86.4±3.8 years). All subjects were in good health according to their clinical history, and none of them had neoplastic, infectious, or autoimmune diseases or received any medications influencing immune function at the time of the study. The study received approval from the local ethics committee, and all participants gave their informed consent. Whole blood was collected by venepuncture in vacutainer tubes containing ethylenediaminetetraacetic acid (EDTA). Peripheral blood mononuclear cells (PBMC) were isolated by density gradient centrifugation on Ficoll-Lympholyte (Cedarlane Laboratories Limited, Ontario, Canada) and stored frozen.
Flow cytometric immunophenotyping of B cell subsets from human peripheral blood of young, elderly, centenarian offspring, and age-matched controls To characterize the phenotype of B lymphocyte subsets, extracellular labeling was performed with anti-CD19-PE, CD24-Pe-Cy7, CD5-V450, IgD-FITC, IgM-PerCPCy5.5 (BD Biosciences), CD27-Qdot605 (Invitrogen), and CD38-eFluor650 (eBioscience). Cell viability was determined with RedVid (Invitrogen). All staining steps were performed in PBS, 2 % FCS, 2 mM EDTA, and 0.01 % Na azide (PFEA) buffer. Blocking of nonspecific binding sites was accomplished using human immunoglobulin Gamunex (Bayer, Leverkusen, Germany) or mouse serum (Caltag/Invitrogen, Karlsruhe, Germany). For each experiment, cells or mouse/rat κ-chain Comp Beads (Becton Dickinson) were stained with the corresponding fluorochrome-labeled antibodies and incubated for 20 min at 4°C in the dark. Human-unstained cells were used as negative controls. After washing with PFEA, the cells or beads were resuspended and measured on a LSR-II flow cytometer using the acquisition software FACSDiva (Becton Dickinson). Data were analyzed using FlowJo software (Tree Star, Portland, OR) . For data analysis, dead cells (RedVid-positive) were excluded. CD19 + living cells were gated within the side/forward scatter (SSC/FSC) lymphocyte gate.
Stimulation of PBMC with cytosine guanine/phorbol myristate acetate/ionomycin for B cell IL-10, IL-6, and TNF production PBMC (10 6 cells/ml) were suspended in X-vivo 15 (Lonza, Walkersville, MD, USA) with or without cytosine guanine (CpG)-B 2006 (3 μg/ml, Tib Molbiol), phorbol myristate acetate (PMA) (50 ng/ml), ionomycin (1 mg/ ml), and monensin sodium salt (2 mM, Sigma Aldrich) in 24-well flat-bottom plates for 5 h, at 37°C (CO 2 5 %). Cells were harvested, washed, and directly stained with anti-CD19-PerCP-Cy5.5, CD24-Pe-Cy7, IgD-FITC, CD180-PE (BD Biosciences), CD27-Qdot605 (Invitrogen), and CD38-eFluor650 (eBioscience). For indirect immunofluorescence, antihuman CD5 (clone UCHT2) culture supernatant hybridoma cell line (Zentrum für Medizinische Forschung, Tübingen, Germany) was used as primary antibody. The secondary antibody was rat anti-mouse PO (Invitrogen). Cells were permeabilized with Citofix/Citoperm (BD Biosciences). Finally, cells were stained with anti-IL-10-APC (Miltenyi Biotec), TNF-AlexaFluor700, and IL-6-V450 (BD Biosciences), washed, and analyzed.
Statistical analyses
All statistical analyses were performed with Graph Pad Prism 4.0 using the Mann-Whitney nonparametric U test to compare two independent groups. Statistical significance was expressed as P<0.05, P<0.01, and P< 0.001 as shown in the figures. All values are expressed as mean±standard error of the mean (SEM).
Results
Characterization of CD38
± /CD24 ± B cell subsets
To better characterize the memory/naïve phenotype of CD38 ± /CD24 ± B cell subsets, we have gated CD19 + CD38 hi CD24 hi "classical transitional," CD19 + CD38 i n t CD24 i n t "mature naïve," and
+ "primarily memory" B cells and further evaluated them on the basis of the expression of IgD and CD27, widely used to identify naïve and memory B cells (Fig. 1) . Moreover, as a fourth population that lacks both CD24 and CD38 is clearly present, we also extended the IgD/CD27 characterization to this population. In the figure, CD19 ). Therefore, during maturation, it seems that B cells progressively modulate both CD38/CD24 and IgD/CD27 expressions, although not synchronously. In order to characterize these populations in more detail, we have evaluated the expression of additional immunological markers (Fig. 2) (Carsetti et al. 2004; Palanichamy et al. 2009; Blair et al. 2010) . Finally, the CD19
) not thus far described was found to be IgM 
CD24
− population, whereas classical transitional, mature naïve, and primarily memory cells were positive for this marker. Results depicted in Fig. 2 are representative of all subjects (young, old, centenarian offspring, and age matched) analyzed.
CpG+PMA/ionomycin stimulates intracellular cytokine production by human blood B cells in vitro A typical feature of aging is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers (Cevenini et al. 2010 ). Memory and naïve B cells can produce different cytokines and chemokines;
in particular, memory B cells produce high levels of the pro-inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α, suggesting that B cells might take part in the generation or in the maintenance of the inflammatory environment of the elderly (Agrawal and Gupta 2011) .
To study the functional properties of peripheral blood B lymphocytes, we tested their ability to produce cytokines "in vitro" on stimulation with a combination of CpG, PMA, and ionomycin. We evaluated the production of IL-10, an anti-inflammatory cytokine, and IL-6 and TNF-α, two pro-inflammatory cytokines, by CD38/CD24 B cell subsets. These cytokines have been extensively studied in aging, as they are involved in the control (IL-10) or maintenance (IL-6 and TNF-α) of inflammation, one of main characteristics of aged people (inflamm-aging) (Franceschi et al. 2000a; Lio et al. 2003; Sanjabi et al. 2009 ). Our analysis revealed that in all the subjects studied, 5 h after stimulation, the main IL-10-producing cells were of the CD19 + CD38 hi CD24 hi phenotype (Table 1 ). In contrast, CD19 + CD38 − CD24 + and CD19
− cells are the more responsive B cell populations involved in TNF-α production ( Table 2) . As no differences were detected (not shown) regarding the age classes, the tables show the mean fluorescent intensity (MFI) values (mean±SEM) of all the subjects studied. On the other hand, this kind of stimulation was not able to induce IL-6 production. Indeed, we did not detect 
− a significant increase in production of IL-6 compared to unstimulated PBMC (not shown).
Age-related changes result in altered distribution of naïve/memory subsets
We have determined whether the distribution of B cell phenotypes including the newly defined subset is different in the elderly compared to the young, and whether this is different in centenarian offspring compared to agematched and elderly controls ( (Fig. 3b) populations between any groups of subjects tested. However, we observed a trend towards higher proportions of CD19
+ cells in the elderly. Interestingly, the percentage of these cells in centenarian offspring are more similar to what is observed in young donors than the age-matched (AM) controls (Fig. 3c) . Most strikingly, the CD19 + CD38 −
− population was highly significantly enriched in the older subjects. Again, their distribution in CO fell between the young and the elderly in the general population (Fig. 3d ).
CD180-negative B cells and CD180 expression on CD38/CD24 and IgD/CD27 B cell subsets in different age groups
It is known that immune system of elderly people shows some characteristics typical of chronically stimulated subjects (CMV-positive elderly subjects and HIV and SLE patients). Moreover, circulating B cells have been reported to lack the TLR-4 homologue CD180 (RP105) in chronically stimulated SLE patients (Koarada and Tada 2012) . We therefore analyzed the percentage of CD19 + CD180 − B lymphocytes in PBMC of young, elderly, CO, and their AM controls. Figure 4a shows a significant increase of this population in the elderly relative to the young. However, no differences were seen between CO and AM controls, although the percentage of CD180 − B cells in CO and AM controls are higher than in the young but lower than in the old donors. Next, we have evaluated the level of expression of CD180 in the four subsets identified on the basis of the markers CD38 and CD24 in the four age groups (Fig. 4b) 
CD27
− ) B cells, we have also evaluated the expression of CD180 on B cell subsets identified on the basis of the expression of IgD and CD27 (Fig. 4c) . Interestingly, in all the subjects, this analysis revealed a progressive decrease of CD180 expression through the different stages of maturation, from naïve (IgD (Fig. 5a) . A comparison between our subjects confirmed (Shi et al. 2005; Buffa et al. 2011 ) a different distribution of B cells identified on the basis of these markers between young and old donors and revealed that CO possess a more "youthfully" distributed immune profile compared with age-matched controls. Indeed, the percentage of IgM + CD27
− (naïve mature) cells (Fig. 5b) are significantly greater in CO, a group of people presumably advantaged for longevity. The analysis of the other two IgM + CD27 + memory B cell phenotypes revealed significantly fewer of these memory cells in the CO (Fig. 5c, d ).
Discussion
During aging, the immune system progressively loses its ability to fight off infections and to respond as quickly or as efficiently to different stimuli. Moreover, the inability of old individuals to effectively respond to vaccines results in less effective immunizations against viruses and bacteria, thus increasing the risk of infections and diseases (Miller and Cancro 2007; Cancro et al. 2009; Gibson et al. 2009; Dunn-Walters and Ademokun 2010; Frasca and Blomberg 2011) . Indeed, it is well documented that the immune response to vaccination declines with age, although the reasons for this are poorly understood (Kumar and Burns 2008; Frasca et al. 2010; McElhaney et al. 2012) . It is also known that in the elderly, there is an impairment of both innate and adaptive immune responses. As we age, the numbers of critical cells in the immune system change, and many may become less functional. However, innate immunity seems to be better preserved, while more severe agedependent changes occur in the adaptive immune system (Franceschi et al. 2000b ). There are clear changes in B cell generation and repertoire, and as a consequence of this and changes in the T cells, elderly people show defective humoral immunity (Cancro et al. 2009; Bulati Fig. (Pawelec et al. 2005; Shi et al. 2005; Frasca et al. 2008; Veneri et al. 2009; , and in previous papers, we (Colonna-Romano et al. 2009 ) and others (Gupta et al. 2005 ) have demonstrated that the percentage of naïve B cells are significantly reduced in aged individuals. However, this is still a somewhat controversial finding as some authors reported an increase, a decrease, or no changes in the naïve/memory B cell compartments, as we have reviewed . The CD27 + memory B cells and, in particular, the IgM memory CD19 
CD27
− cells, a DN memory B cell population, in the elderly (ColonnaRomano et al. 2009 ). This population is also expanded in subjects chronically stimulated (Anolik et al. 2004; Wei et al. 2007; Sanz et al. 2008; Cagigi et al. 2009 ) and might be considered the result of long-enduring stimulation. However, not all subjects or population groups are equally susceptible to the effects of long-term chronic stimulation of the immune system. Indeed, recent evidence has shown a well-preserved immune profile of a group of healthy elderly centenarian offspring who seem to have genetic and functional advantages associated with the reduced risk of disability with age (Terry et al. 2003 (Terry et al. , 2004 . We have demonstrated that the naïve B cells subset is well preserved in CO compared with the age- matched controls. The mirror image of this is a more restricted memory pool, which includes, in addition, a less expanded DN compartment . Collectively, our data suggest age-related changes, but they are of course cross-sectional in the present study and therefore can only formally demonstrate differences between groups. Other investigations, such as a longitudinal follow-up studies, will be necessary to affirm a real age-related change.
Recently, several new B cell populations have been described, although their phenotype has not been always associated with established biological function. In the present work, we gained insight into the naïve/memory B cell compartment focusing, in particular, on the different age groups analyzed. According to the gating strategy proposed by Carsetti et al. (2004) , our study has focused on four distinct B cell populations: CD19
+ (primarily memory), and in addition, a not previously described CD19
A previous study reported that the frequency of transitional B cells is rapidly reduced during the first years of life, stabilizing after 5 years of age (Morbach et al. 2010) . Here, we found that there are no differences in the percentage of transitional and mature naïve B cells, comparing young and the three different groups of old donors CO, AM, and elderly, but we did observe a higher proportion of CD19
+ primarily memory cells in young and CO compared to AM, although the difference did not achieve statistical significance. However, the higher percentage of naïve mature cells compared to the elderly. A direct comparison between CO and aged people (AM and old subjects) emphasizes that the former shows a significantly higher percentage of this IgM population. c A substantial and significant age-related decrease was observed in the natural effector subset. d Age-related decrease of the IgM-only B cell subset observed in old and age-matched controls compared with young and centenarian offspring subjects. Differences between age groups were analyzed with the Mann-Whitney test. *P<0.05; **P<0.01; ***P<0.001
− putative new population was significantly increased in the elderly, and the percentage of this population in CO is more similar to that observed in young than in elderly or age-matched donors. This may therefore contribute to their immunological "youthfulness." Apart from this, the other B cell populations identified on the basis of the expression of CD38/CD24 show the same distribution in the different groups studied. 
− DN B cells that are increased in the elderly but not in CO (Colonna-Romano et al. 2009 . It is of note that a fraction of the IgD − CD27 + subset also includes IgD
+ memory B cells that we and others have described as being decreased in the elderly (Shi et al. 2005; Buffa et al. 2011) . Probably, their low percenta g e d o e s n o t i n f l u e n c e t h e p e r c e n t a g e o f CD19
− B cells in the different age groups. 
CD24
− cells were also positive for the same marker. This molecule is present in adulthood on all B cell subsets, but at a low and variable frequency. CD5 expression is associated with the presence of the B cell receptor (BCR), and it appears in the bone marrow; it has been shown to be a negative regulator of BCR signaling, and its expression may be a marker of antigen exposure (Gary-Gouy et al. 2000 , 2002 Carsetti et al. 2004) . Additional characterization of these CD19
− B lymphocytes has demonstrated here that almost all are CD180 negative. This marker, also known as RP105, is a toll-like receptor-associated molecule, originally identified as a B cell surface molecule mediating activation and proliferation in mice. Data from the literature indicate that RP105-deficient mice are hypo-responsive to TLR-4 and TLR-2 stimulation (Ogata et al. 2000; Nagai et al. 2005) . Recently, increasing interest in this molecule has led several investigators to evaluate CD180 in humans and, in particular, in subjects suffering from autoimmune diseases. It has been demonstrated that the percentage of CD180-negative B cells are significantly increased in systemic lupus erythematosus and, to a lesser extent, in rheumatoid arthritis patients, compared to healthy controls. Its expression declines during the inactive stages of disease, suggesting that the expansion of this population is correlated with disease activity (Koarada and Tada 2012) . The phenotypic characterization of the abovedescribed subset has defined a profile of activated B cells producing immunoglobulins and anti-dsDNA antibodies. Moreover, approximately 50 % of these CD180-negative B cells had intracellular IgG (Koarada et al. 1999) , suggesting that they could be induced to differentiate into IgG-secreting B cells by certain stimuli. As autoimmune phenomena are a common feature in the elderly, we have evaluated the expression of this marker on total B lymphocytes in different age groups, observing a reduced expression with age. Indeed, CD180-negative B cells are significantly increased in the very elderly donors (age range 86.4±3.8) when compared to the young (age range 28.5±1.9), but not in CO and AM (age range 70.1 ± 8.3 and 69.1 ± 9, respectively). Furthermore, we assessed the level of expression of CD180 in the four subsets identified on the basis of the markers CD38 and CD24 in the four age groups. In any event, our comparative analysis between young, CO, AM, and O subjects did not reveal age-associated differences in the level of CD180 expression. Interestingly, the evaluation of CD38 (Berkowska et al. 2011 ), based on the major subset of CD38 dim CD24 dim . We analyzed IgM B cell subsets, comparing data between subjects included in this study.
We have confirmed data from the literature demonstrating impairment decrease of IgM B lymphocytes in the elderly (Shi et al. 2005; Buffa et al. 2011) . On the contrary, a further evaluation of CO B cell populations revealed that the percentage of these cells are not reduced to the same extent as their age-matched controls and remain more similar to that observed in young people. These data reinforce our previous hypothesis according to which CO have a younger B cell profile. This hypothesis is corroborated by the reduced number of CD19 + CD38 −
− B cells and a higher level of IgM B cell subsets in CO, compared to AM donors. This immunological advantage, likely due to a good bone marrow reservoir, could help CO both to fight the main age-related diseases and to maintain healthy aging. Here, we have also performed a preliminary functional study on the CD38/CD24 B cells to better understand their biological role and function. We tested their ability to produce pro-and anti-inflammatory cytokines on strong stimulation with CpG/PMA/ionomycin in vitro. We know that cytokines are considered key players in maintaining lymphocyte homeostasis. Their function is to induce and modulate the nature of the response after an immune insult, or in contrast, they may cause non-responsiveness and active immune suppression (Sanjabi et al. 2009 ). Moreover, it is known that elderly people show a pro-inflammatory microenvironment that has been related to the increased risk of morbidity and mortality (Licastro et al. 2005; Vasto et al. 2007 ). Concerning the anti-inflammatory cytokine IL-10, also our stimulation system provides data consistent with a biological role of CD19 + CD38 hi
hi cells as regulatory cells, i.e., a B cell population involved in IL-10 production. Our comparative analysis did not reveal any differences between the four age groups analyzed. We have previously demonstrated that under the same conditions, IgD + CD27
− (naïve) B cells produce high levels of IL-10 in the elderly subsets, which seem to be sensitive to biological and not chronological aging, are the main B cells involved in the in vitro production of this pro-inflammatory cytokine, with no differences between the groups studied. At the present time, we cannot state which population is more responsible for the impaired cytokine production. Nonetheless, as TNF-α is a pro-inflammatory cytokine recently reported to be increased in a mouse model made of aged B cells (Frasca et al. 2012) , we hypothesize that switched memory (IgD − CD27 + ) and/or DN (IgD − CD27 − ) B cells could be responsible for this cytokine production. We suggest that the expansion of these B cell subsets in the elderly might contribute to the increased inflammatory status designated "inflammaging."
Taken together, our data document the phenotypic and biological characteristics of a CD19 + CD38 − CD24 − B cell population and suggest that these cells might act as memory B cells involved in inflammation. Analysis with additional markers, such as IgG, IgA, HLA, CD138, CD43, and CD70, may be useful for a deeper characterization of this subset, as well as investigating them under pathological conditions. We also need to evaluate if they might act as antibody (Ab)-producing cells or develop into Ab-secreting cells, and in particular, whether these cells could be responsible for autoantibody production. Moreover, our data emphasize that modifications to B cell immunity could play a pivotal role during processes associated with aging. A better understanding of B cell immunosenescence is crucial for the improvement of the quality of life of the growing elderly population worldwide. Hence, B cell immune profiling must be included in any attempts to develop useful biomarkers of human immunosenescence. The study of B cell phenotypes in the peripheral blood of centenarian offspring revealed that many parameters are well preserved and more closely resemble that of the young than of either their age-matched controls or old subjects. In any event, other immune parameters, such as CD180 expression and cytokine production, seem not suggest a complete preservation of the B cell branch in the offspring of long-lived subjects. Further analyses are necessary to correlate the environmental and genetic background with a well-preserved immune system of centenarian offspring that could support the hypothesis of a "familial youth" of the immune system.
